Immune-Mediated Hematologic Complications of Checkpoint Inhibitors: A Review of the Literature

Conclusion:Immune-mediated hematologic complications associated with checkpoint inhibitors are rare. They are usually reversible after discontinuation of such treatment. Relapses may occur with re-challenge.DisclosuresNo relevant conflicts of interest to declare.

Source: Blood - November 21, 2018 Category: Hematology Authors: Sallam, O., Riaz, I. B., Go, R. S. Tags: 903. Outcomes Research-Non-Malignant Hematology Source Type: research